AnalystsMichael MorabitoMichael Morabito's Stock Forecasts
AnalystsMichael Morabito
Sectors:
Analyst Ranking
Bottom 5%
#4334 out of 4554 analysts
Average Return
-25.58%
Win Rate
19%3 out of 16
Risk vs Reward
Poor
Good
Michael Morabito's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Madrigal Pharmaceuticals IncMDGL | +46.71% | $88.31 | $129.56 | 2020-05-04 - 2021-05-05 | Strong Buy |
Ngm Biopharmaceuticals IncNGM | +28.14% | $17.91 | $22.95 | 2020-08-12 - 2021-08-11 | Strong Buy |
Ngm Biopharmaceuticals IncNGM | +9.31% | $19.97 | $21.83 | 2020-07-06 - 2021-07-07 | Strong Buy |
Michael Morabito Analyst Color
Get additional color on Michael Morabito's coverage of popular stocks
Michael Morabito's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Akero Therapeutics IncAKRO | 2 | Strong Buy | $81.00 | N/A | Maintains | 3 years ago |
Ngm Biopharmaceuticals IncNGM | 3 | Strong Buy | $44.00 | N/A | Maintains | 3 years ago |
Madrigal Pharmaceuticals IncMDGL | 2 | Strong Buy | $203.00 | N/A | Maintains | 3 years ago |
Durect CorpDRRX | 2 | Strong Buy | $80.00 | N/A | Maintains | 3 years ago |
Intercept Pharmaceuticals IncICPT | 2 | Strong Buy | $58.00 | N/A | Maintains | 3 years ago |
Axcella Health IncAXLA | 1 | Strong Buy | $400.00 | N/A | Initiates Coverage On | 3 years ago |
89bio IncETNB | 2 | Strong Buy | $95.00 | N/A | Maintains | 4 years ago |
Viking Therapeutics IncVKTX | 2 | Strong Buy | $20.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.